Antigenic Peptides Derived From Telomerase


The full document isn't yet available to us from the patent office.


This invention relates to proteins or peptides which elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognising and destroying tumour cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.


Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: May 4, 2011
  • Application: Jun 30, 1999
    EP EP 10183808 A
  • Priority: Jun 30, 1999
    EP EP 10154215 A
  • Priority: Jun 30, 1999
    EP EP 03075681 A
  • Priority: Jun 30, 1999
    EP EP 99928238 A
  • Priority: Jul 8, 1998
    NO NO 983141 A

Download Citation

Sign in to the Lens